Each year, the Cleveland Clinic puts on a Medical Innovation Summit focusing on a specific therapeutic category. This year the subject was cancer – though its business speakers focused their remarks more broadly.
On October 5th, the Summit’s opening day, we had the chance to interview two of the featured speakers – Dave Brennan, CEO of AstraZeneca, and Dan Vasella, the CEO of Novartis.
Today, we’ll show you our discussion with Dave, which followed his talk (here’s a link to the text) focusing on the triple themes of personalization, partnerships (which is to say: externalization), and policy.
Our conversation (and the questions from the audience) went far beyond those subjects, however. To see and hear it, click here.
On October 5th, the Summit’s opening day, we had the chance to interview two of the featured speakers – Dave Brennan, CEO of AstraZeneca, and Dan Vasella, the CEO of Novartis.
Today, we’ll show you our discussion with Dave, which followed his talk (here’s a link to the text) focusing on the triple themes of personalization, partnerships (which is to say: externalization), and policy.
Our conversation (and the questions from the audience) went far beyond those subjects, however. To see and hear it, click here.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.